Literature DB >> 15155212

Efficacies of amphotericin B (AMB) lipid complex, AMB colloidal dispersion, liposomal AMB, and conventional AMB in treatment of murine coccidioidomycosis.

Gloria M González1, Rolando Tijerina, Laura K Najvar, Rosie Bocanegra, Michael G Rinaldi, John R Graybill.   

Abstract

The therapeutic efficacy of three lipid formulations of amphotericin B was compared with that of conventional amphotericin B in treatment of murine coccidioidomycosis. All treatments prolonged survival compared with the no-treatment group (P < 0.0001). Although conventional amphotericin B was more active than lipid formulations on reducing quantitative fungal load on a milligram-per-kilogram basis (P < 0.003 to 0.0002), the lipid preparations could be administered at higher doses, sterilizing liver and spleen tissues. The efficacies of the lipid preparations were similar in this murine model of coccidioidomycosis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15155212      PMCID: PMC415584          DOI: 10.1128/AAC.48.6.2140-2143.2004

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  15 in total

1.  Comparison of fungizone, Amphotec, AmBisome, and Abelcet for treatment of systemic murine cryptococcosis.

Authors:  K V Clemons; D A Stevens
Journal:  Antimicrob Agents Chemother       Date:  1998-04       Impact factor: 5.191

Review 2.  Amphotericin B: a commentary on its role as an antifungal agent and as a comparative agent in clinical trials.

Authors:  H A Gallis
Journal:  Clin Infect Dis       Date:  1996-05       Impact factor: 9.079

3.  Liposomal amphotericin B therapy of murine histoplasmosis.

Authors:  J R Graybill; R Bocanegra
Journal:  Antimicrob Agents Chemother       Date:  1995-08       Impact factor: 5.191

Review 4.  Diversity of lipid-based polyene formulations and their behavior in biological systems.

Authors:  K M Wasan; G Lopez-Berestein
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1997-01       Impact factor: 3.267

Review 5.  Biopharmaceutical aspects of lipid formulations of amphotericin B.

Authors:  G Storm; E van Etten
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1997-01       Impact factor: 3.267

Review 6.  A comparative review of conventional and lipid formulations of amphotericin B.

Authors:  R F Robinson; M C Nahata
Journal:  J Clin Pharm Ther       Date:  1999-08       Impact factor: 2.512

Review 7.  Do variations in molecular structure affect the clinical efficacy and safety of lipid-based amphotericin B preparations?

Authors:  J Mehta
Journal:  Leuk Res       Date:  1997-03       Impact factor: 3.156

Review 8.  Lipid formulations of amphotericin B: clinical efficacy and toxicities.

Authors:  A Wong-Beringer; R A Jacobs; B J Guglielmo
Journal:  Clin Infect Dis       Date:  1998-09       Impact factor: 9.079

9.  Efficacy of AmBisome in murine coccidioidomycosis.

Authors:  M M Albert; K Adams; M J Luther; S H Sun; J R Graybill
Journal:  J Med Vet Mycol       Date:  1994-12

10.  Amphotericin B lipid complex for invasive fungal infections: analysis of safety and efficacy in 556 cases.

Authors:  T J Walsh; J W Hiemenz; N L Seibel; J R Perfect; G Horwith; L Lee; J L Silber; M J DiNubile; A Reboli; E Bow; J Lister; E J Anaissie
Journal:  Clin Infect Dis       Date:  1998-06       Impact factor: 9.079

View more
  4 in total

1.  Comparison of the physicochemical, antifungal, and toxic properties of two liposomal amphotericin B products.

Authors:  Jon A Olson; Jill P Adler-Moore; Gerard M Jensen; Julie Schwartz; M Cecilia Dignani; Richard T Proffitt
Journal:  Antimicrob Agents Chemother       Date:  2007-10-29       Impact factor: 5.191

2.  Evaluation of Amphotericin B Lipid Formulations for Treatment of Severe Coccidioidomycosis.

Authors:  Ritam Sidhu; David B Lash; Arash Heidari; Piruthiviraj Natarajan; Royce H Johnson
Journal:  Antimicrob Agents Chemother       Date:  2018-06-26       Impact factor: 5.191

Review 3.  The Rise of Coccidioides: Forces Against the Dust Devil Unleashed.

Authors:  Marley C Caballero Van Dyke; George R Thompson; John N Galgiani; Bridget M Barker
Journal:  Front Immunol       Date:  2019-09-11       Impact factor: 7.561

Review 4.  Coccidioidomycosis: A Contemporary Review.

Authors:  Nancy F Crum
Journal:  Infect Dis Ther       Date:  2022-03-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.